Email Sign Up
  • Home
  • About Us
    • Anatara Overview
    • Board of Directors
    • Our Team
    • Advisory Boards
  • Clinical Trials
    • Irritable Bowel Syndrome
    • Psychological Health
  • Products and Pipeline
    • Human Applications
    • Irritable Bowel Syndrome
    • Inflammatory Bowel Disease
    • Animal Applications
    • Partnering
  • Investor Centre
    • Investors Home
    • Corporate Factsheet
    • Annual Reports
    • ASX Announcements
    • Analysts’ Reports
    • Financial Reports
    • Presentations
    • Events
    • Corporate Governance
    • Corporate Directory
  • Media Centre
    • Top Stories
    • Media Coverage
    • Multimedia Gallery
    • Anatara e-news
    • Industry Links
    • Media Contacts
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
  • Home
  • About Us
    • Anatara Overview
    • Board of Directors
    • Our Team
    • Advisory Boards
  • Clinical Trials
    • Irritable Bowel Syndrome
    • Psychological Health
  • Products and Pipeline
    • Human Applications
    • Irritable Bowel Syndrome
    • Inflammatory Bowel Disease
    • Animal Applications
    • Partnering
  • Investor Centre
    • Investors Home
    • Corporate Factsheet
    • Annual Reports
    • ASX Announcements
    • Analysts’ Reports
    • Financial Reports
    • Presentations
    • Events
    • Corporate Governance
    • Corporate Directory
  • Media Centre
    • Top Stories
    • Media Coverage
    • Multimedia Gallery
    • Anatara e-news
    • Industry Links
    • Media Contacts
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Home > Media Centre > Media Coverage > Uncategorized > Formation of Product Development Advisory Board

Formation of Product Development Advisory Board

Anatara Lifesciences is pleased to announce the formation of its Product Development Advisory Board.

Please click Anatara Product Development Advisory Board for the ASX announcement.

  • Home
  • About Us
    • Anatara Overview
    • Board of Directors
    • Our Team
    • Advisory Boards
  • Clinical Trials
    • Irritable Bowel Syndrome
    • Psychological Health
  • Products and Pipeline
    • Human Applications
    • Irritable Bowel Syndrome
    • Inflammatory Bowel Disease
    • Animal Applications
    • Partnering
  • Investor Centre
    • Investors Home
    • Corporate Factsheet
    • Annual Reports
    • ASX Announcements
    • Analysts’ Reports
    • Financial Reports
    • Presentations
    • Events
    • Corporate Governance
    • Corporate Directory
  • Media Centre
    • Top Stories
    • Media Coverage
    • Multimedia Gallery
    • Anatara e-news
    • Industry Links
    • Media Contacts
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Email Sign Up
© 2022 Anatara Lifesciences Ltd | Privacy